- Associated Press•3 days ago
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of $1.50. The results did not meet Wall Street expectations. The average estimate of nine analysts surveyed by Zacks ...
- Business Wire•3 days agoSage Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update
Sage Therapeutics, Inc. today reported business highlights and financial results for the fourth quarter and full year ended December 31, 2016.
- Forbes•4 days ago
Sage Therapeutics has been whipping its investors into a frenzy of late. But there are important milestones coming this year that the biotech will have to cross to live up to high expectations.
SAGE : Summary for Sage Therapeutics, Inc. - Yahoo Finance
Sage Therapeutics, Inc. (SAGE)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||57.00 x 200|
|Day's Range||60.52 - 62.97|
|52 Week Range||26.28 - 66.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-14.84|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|